From Intermediate to Innovation: The Role of Ethyl 6-(4-Aminophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate in Drug Discovery
The journey of a drug from concept to patient is often paved with complex chemical intermediates. NINGBO INNO PHARMCHEM CO.,LTD. plays a vital role in this journey by providing essential chemical compounds, such as Ethyl 6-(4-Aminophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate (CAS: 503615-07-4).
While primarily known as an impurity and intermediate in the synthesis of Apixaban, a leading anticoagulant, this compound holds potential for broader applications in drug discovery. The intricate heterocyclic structure of C22H22N4O4 (molecular weight 406.43) makes it an attractive starting point or research tool for scientists exploring new therapeutic targets.
NINGBO INNO PHARMCHEM CO.,LTD. supports the pharmaceutical research community by offering well-characterized chemical entities. For compounds like CAS 503615-07-4, this includes providing detailed analytical data and ensuring purity, which are critical for reliable experimental results. Researchers investigating novel treatments for thromboembolic disorders or exploring alternative pathways in drug development may find this molecule a valuable component in their studies.
The significance of Ethyl 6-(4-Aminophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate lies not only in its established role but also in its potential as a scaffold for new chemical entities. As the pharmaceutical industry constantly seeks innovative solutions, the availability of such versatile intermediates from reliable suppliers like NINGBO INNO PHARMCHEM CO.,LTD. is crucial.
By understanding the chemistry of these compounds, NINGBO INNO PHARMCHEM CO.,LTD. aims to facilitate breakthroughs in medicine. Our commitment to quality and accessibility ensures that researchers have the tools they need to push the boundaries of drug discovery, transforming potential into life-saving treatments.
Perspectives & Insights
Quantum Pioneer 24
“While primarily known as an impurity and intermediate in the synthesis of Apixaban, a leading anticoagulant, this compound holds potential for broader applications in drug discovery.”
Bio Explorer X
“43) makes it an attractive starting point or research tool for scientists exploring new therapeutic targets.”
Nano Catalyst AI
“supports the pharmaceutical research community by offering well-characterized chemical entities.”